ferrous sulfate Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4528 7720-78-7

Description:

MoleculeDescription

Synonyms:

  • ferrous sulfate
  • ferrous sulfate, dried
Ferro-Gradumet is ferrous sulfate in controlled release form; RN given refers to Fe(+2)[1:1] salt
  • Molecular weight: 151.90
  • Formula: FeO4S
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 80.26
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
0.20 g O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 3 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 570 mg/mL Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 30.56 ┬ÁM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD

Approvals:

DateAgencyCompanyOrphan
Aug. 13, 1946 FDA LEDERLE

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug ineffective 210.97 10.15 286 50783 816959 52481038
Anaemia 191.75 10.15 641 50428 276077 53021920
Acute kidney injury 158.28 10.15 568 50501 253300 53044697
Rheumatoid arthritis 149.81 10.15 57 51012 314474 52983523
Completed suicide 86.99 10.15 14 51055 138187 53159810
Treatment failure 80.83 10.15 13 51056 128390 53169607
Drug intolerance 78.44 10.15 50 51019 205443 53092554
Haemoglobin decreased 75.19 10.15 295 50774 137012 53160985
Contraindicated product administered 74.44 10.15 19 51050 135610 53162387
Fluid overload 71.28 10.15 109 50960 27722 53270275
Gastrointestinal haemorrhage 69.18 10.15 201 50868 80129 53217868
Iron deficiency anaemia 68.95 10.15 87 50982 18493 53279504
Hand deformity 68.39 10.15 3 51066 84846 53213151
Premature delivery 67.93 10.15 103 50966 26001 53271996
Systemic lupus erythematosus 66.13 10.15 19 51050 125395 53172602
Hepatic enzyme increased 58.11 10.15 24 51045 126171 53171826
Joint swelling 56.24 10.15 86 50983 234552 53063445
Hyperkalaemia 52.84 10.15 142 50927 54114 53243883
Alopecia 51.54 10.15 91 50978 234492 53063505
Glossodynia 51.40 10.15 16 51053 100275 53197722
Drug hypersensitivity 48.81 10.15 114 50955 265128 53032869
Melaena 46.95 10.15 93 50976 29036 53268961
Therapeutic product effect decreased 45.99 10.15 32 51037 125623 53172374
Arthropathy 44.33 10.15 42 51027 141411 53156586
Discomfort 41.05 10.15 20 51049 95452 53202545
Musculoskeletal stiffness 40.60 10.15 35 51034 123333 53174664
Pulmonary arterial hypertension 39.46 10.15 83 50986 27039 53270958
Arthralgia 38.92 10.15 254 50815 439529 52858468
Pericarditis 37.35 10.15 8 51061 64398 53233599
Pulmonary hypertension 36.74 10.15 98 50971 37172 53260825
Faeces discoloured 36.74 10.15 63 51006 17623 53280374
Foetal exposure during pregnancy 34.95 10.15 92 50977 34623 53263374
Cardiac failure acute 34.41 10.15 43 51026 9049 53288948
Transfusion 34.19 10.15 53 51016 13634 53284363
Hypoxia 34.05 10.15 124 50945 55556 53242441
Metabolic alkalosis 34.01 10.15 26 51043 2993 53295004
Hyponatraemia 33.61 10.15 198 50871 108409 53189588
Gastrointestinal tract mucosal pigmentation 33.59 10.15 15 51054 625 53297372
Acute respiratory failure 32.66 10.15 84 50985 31174 53266823
Right ventricular failure 32.39 10.15 58 51011 16785 53281212
Pain 31.70 10.15 386 50683 588012 52709985
Hypersensitivity 31.62 10.15 100 50969 210565 53087432
Congenital ovarian anomaly 31.56 10.15 6 51063 6 53297991
Toxicity to various agents 30.39 10.15 108 50961 219490 53078507
Wound 30.09 10.15 26 51043 91531 53206466
Lactic acidosis 29.94 10.15 91 50978 37162 53260835
Abdominal discomfort 29.74 10.15 110 50959 220952 53077045
Dyspnoea 29.35 10.15 751 50318 585481 52712516
Hospitalisation 29.17 10.15 140 50929 70872 53227125
Urinary tract infection 28.56 10.15 353 50716 239550 53058447
Therapeutic product effect incomplete 27.88 10.15 28 51041 91756 53206241
Transferrin saturation increased 27.67 10.15 7 51062 45 53297952
Cardiac failure congestive 27.35 10.15 167 50902 92590 53205407
Maternal exposure during breast feeding 27.11 10.15 24 51045 3393 53294604
Helicobacter infection 26.84 10.15 3 51066 39066 53258931
Blood loss anaemia 26.11 10.15 37 51032 8786 53289211
Pneumonia 26.04 10.15 540 50529 406629 52891368
Metabolic acidosis 25.76 10.15 94 50975 42148 53255849
International normalised ratio increased 25.60 10.15 102 50967 47659 53250338
Dyspnoea exertional 24.48 10.15 111 50958 54889 53243108
Transferrin increased 24.28 10.15 5 51064 10 53297987
Hypokalaemia 23.71 10.15 166 50903 96351 53201646
Pulmonary malformation 23.70 10.15 8 51061 154 53297843
Fluid retention 23.62 10.15 109 50960 54292 53243705
Autoimmune haemolytic anaemia 23.41 10.15 25 51044 4446 53293551
Hypotension 23.35 10.15 357 50712 253719 53044278
Haematocrit decreased 22.70 10.15 83 50986 37248 53260749
Blood iron decreased 22.11 10.15 41 51028 12187 53285810
Infusion related reaction 22.03 10.15 76 50993 155881 53142116
Gingival hypertrophy 21.53 10.15 15 51054 1496 53296501
Hypoglycaemia 21.18 10.15 112 50957 58901 53239096
Fall 21.17 10.15 470 50599 357970 52940027
Drug abuse 21.05 10.15 19 51050 65507 53232490
Haematochezia 20.76 10.15 88 50981 42270 53255727
Spinal epidural haematoma 20.71 10.15 12 51057 869 53297128
Epistaxis 20.43 10.15 124 50945 68586 53229411
Haemoptysis 19.35 10.15 65 51004 27974 53270023
Congenital skin dimples 19.26 10.15 7 51062 169 53297828
Oesophageal injury 18.81 10.15 5 51064 40 53297957
Rectal haemorrhage 18.67 10.15 84 50985 41397 53256600
Packed red blood cell transfusion 18.53 10.15 16 51053 2187 53295810
Diastasis recti abdominis 18.29 10.15 5 51064 45 53297952
Asthenia 17.96 10.15 443 50626 343147 52954850
Sight disability 17.75 10.15 6 51063 116 53297881
Oedema 17.75 10.15 127 50942 74219 53223778
Foetal death 17.73 10.15 32 51037 9315 53288682
Mental status changes 17.71 10.15 80 50989 39491 53258506
Thermohypoaesthesia 17.70 10.15 6 51063 117 53297880
Subdural haematoma 17.51 10.15 40 51029 13773 53284224
Chronic kidney disease 17.44 10.15 85 50984 43285 53254712
Glucocorticoids increased 17.29 10.15 6 51063 126 53297871
Hypoosmolar state 17.26 10.15 7 51062 229 53297768
Renal arteriosclerosis 17.15 10.15 5 51064 58 53297939
Lung cyst 17.07 10.15 6 51063 131 53297866
Constipation 16.78 10.15 275 50794 198137 53099860
Hypothermia 16.76 10.15 38 51031 13018 53284979
Exposure during pregnancy 16.72 10.15 188 50881 124672 53173325
Cellulitis 16.54 10.15 127 50942 75862 53222135
N-terminal prohormone brain natriuretic peptide increased 16.37 10.15 14 51055 1890 53296107
Folliculitis 16.34 10.15 5 51064 31704 53266293
Oxygen consumption increased 16.29 10.15 19 51050 3722 53294275
Cardiac failure 16.27 10.15 139 50930 85705 53212292
Therapeutic response decreased 16.25 10.15 13 51056 47556 53250441
General physical health deterioration 16.12 10.15 79 50990 146863 53151134
Internal haemorrhage 15.87 10.15 21 51048 4675 53293322
Vulvovaginal warts 15.78 10.15 3 51066 3 53297994
Discharge 15.63 10.15 10 51059 866 53297131
Respiratory tract malformation 15.56 10.15 5 51064 82 53297915
Sinus node dysfunction 15.51 10.15 20 51049 4341 53293656
Uterine leiomyoma 15.49 10.15 29 51040 8683 53289314
Psoriatic arthropathy 15.45 10.15 14 51055 48176 53249821
Haemorrhagic erosive gastritis 15.42 10.15 7 51062 303 53297694
Product use issue 15.34 10.15 75 50994 139509 53158488
Congenital musculoskeletal anomaly 15.15 10.15 8 51061 483 53297514
Azotaemia 14.97 10.15 20 51049 4493 53293504
Urticaria 14.94 10.15 73 50996 135812 53162185
Impaired healing 14.91 10.15 24 51045 64181 53233816
Abdominal pain 14.90 10.15 335 50734 255568 53042429
Chest pain 14.77 10.15 260 50809 189925 53108072
Haemoglobin abnormal 14.63 10.15 20 51049 4594 53293403
Quadriplegia 14.52 10.15 13 51056 1865 53296132
Blood creatine phosphokinase MM increased 14.44 10.15 4 51065 38 53297959
Pre-eclampsia 14.40 10.15 28 51041 8619 53289378
Hepatic encephalopathy 14.38 10.15 32 51037 10827 53287170
Rash 14.26 10.15 322 50747 445869 52852128
Chronic obstructive pulmonary disease 13.82 10.15 103 50966 60970 53237027
Oedema peripheral 13.81 10.15 235 50834 170552 53127445
Sopor 13.78 10.15 48 51021 21036 53276961
Foetal malnutrition 13.74 10.15 5 51064 121 53297876
Death 13.74 10.15 443 50626 356789 52941208
Dehydration 13.71 10.15 232 50837 168178 53129819
Clostridium difficile infection 13.70 10.15 58 51011 27835 53270162
Infected neoplasm 13.66 10.15 6 51063 240 53297757
Off label use 13.65 10.15 346 50723 471866 52826131
Maternal exposure during pregnancy 13.63 10.15 217 50852 155422 53142575
Diarrhoea 13.59 10.15 730 50339 624816 52673181
Uterine perforation 13.57 10.15 25 51044 7394 53290603
Genital prolapse 13.45 10.15 4 51065 50 53297947
Hypomagnesaemia 13.30 10.15 53 51016 24758 53273239
Respiratory failure 13.30 10.15 151 50918 100361 53197636
Renal tubular acidosis 13.30 10.15 12 51057 1739 53296258
Sepsis 13.14 10.15 205 50864 146224 53151773
Threatened labour 13.13 10.15 9 51060 874 53297123
Atrial fibrillation 13.13 10.15 164 50905 111488 53186509
Troponin increased 13.08 10.15 27 51042 8678 53289319
Total bile acids increased 12.93 10.15 5 51064 144 53297853
Talipes 12.82 10.15 11 51058 1491 53296506
Blister 12.79 10.15 36 51033 78717 53219280
Musculoskeletal pain 12.50 10.15 34 51035 75166 53222831
Postpartum haemorrhage 12.40 10.15 12 51057 1900 53296097
Foetal macrosomia 12.31 10.15 4 51065 68 53297929
Live birth 12.30 10.15 37 51032 15022 53282975
Mobility decreased 12.29 10.15 35 51034 76236 53221761
Hypermagnesaemia 12.09 10.15 9 51060 996 53297001
Arteriovenous malformation 12.01 10.15 10 51059 1301 53296696
Injection site reaction 12.00 10.15 19 51050 51147 53246850
Hypovolaemia 11.96 10.15 29 51040 10373 53287624
Intentional product misuse 11.91 10.15 18 51051 49374 53248623
Full blood count decreased 11.83 10.15 50 51019 23979 53274018
Caesarean section 11.81 10.15 40 51029 17280 53280717
C-reactive protein increased 11.81 10.15 30 51039 67856 53230141
Coma 11.79 10.15 26 51043 61757 53236240
Heavy menstrual bleeding 11.74 10.15 40 51029 17336 53280661
Resting tremor 11.73 10.15 8 51061 771 53297226
Application site haematoma 11.64 10.15 3 51066 21 53297976
Maternal condition affecting foetus 11.55 10.15 5 51064 193 53297804
Abdominal distension 11.53 10.15 122 50947 79668 53218329
Ketosis 11.50 10.15 7 51062 555 53297442
Haematemesis 11.37 10.15 59 51010 30798 53267199
Psoriasis 11.26 10.15 44 51025 87045 53210952
Iron deficiency 11.23 10.15 21 51048 6279 53291718
Clostridium difficile colitis 11.23 10.15 43 51026 19722 53278275
Swelling 11.15 10.15 123 50946 190982 53107015
Periodontitis 11.08 10.15 15 51054 3414 53294583
Haematocrit abnormal 11.02 10.15 8 51061 851 53297146
Sinus arrest 10.89 10.15 11 51058 1833 53296164
Haemoperitoneum 10.83 10.15 13 51056 2624 53295373
Upper gastrointestinal haemorrhage 10.80 10.15 39 51030 17391 53280606
Pulmonary oedema 10.71 10.15 88 50981 53635 53244362
Premature labour 10.69 10.15 31 51038 12331 53285666
Psychomotor skills impaired 10.56 10.15 12 51057 2287 53295710
Meningism 10.54 10.15 6 51063 420 53297577
Haemorrhage 10.52 10.15 93 50976 57894 53240103
Umbilical discharge 10.41 10.15 4 51065 113 53297884
Cellulitis orbital 10.30 10.15 6 51063 439 53297558
Tubulointerstitial nephritis 10.29 10.15 37 51032 16467 53281530
Cytomegalovirus infection 10.22 10.15 3 51066 19536 53278461

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Anaemia 83.93 10.83 397 27549 223227 32262353
Acute kidney injury 81.36 10.83 479 27467 292989 32192591
Foetal exposure during pregnancy 66.74 10.83 124 27822 41177 32444403
Completed suicide 60.79 10.83 5 27941 92512 32393068
Drug ineffective 59.75 10.83 153 27793 383324 32102256
Faeces discoloured 58.48 10.83 68 27878 14809 32470771
Gastrointestinal haemorrhage 57.73 10.83 185 27761 86697 32398883
Premature baby 51.14 10.83 71 27875 18447 32467133
Hyperkalaemia 49.52 10.83 152 27794 69598 32415982
Foetal disorder 42.12 10.83 18 27928 752 32484828
Periodontitis 36.74 10.83 22 27924 1889 32483691
Haemoglobin decreased 36.69 10.83 201 27745 119470 32366110
Drug abuse 36.04 10.83 12 27934 80231 32405349
Neutropenia neonatal 34.61 10.83 15 27931 649 32484931
Iron deficiency anaemia 34.27 10.83 42 27904 9659 32475921
Blood loss anaemia 34.00 10.83 38 27908 7924 32477656
Lymph node calcification 33.18 10.83 11 27935 224 32485356
Clostridium difficile infection 32 10.83 56 27890 17740 32467840
Encephalitis toxic 31.92 10.83 11 27935 253 32485327
Asthenia 30.40 10.83 323 27623 235621 32249959
Febrile neutropenia 29.09 10.83 36 27910 119530 32366050
Fall 27.34 10.83 273 27673 195928 32289652
Hyperlactacidaemia 25.18 10.83 21 27925 3053 32482527
Urinary tract infection 24.86 10.83 135 27811 79936 32405644
Toxicity to various agents 24.65 10.83 75 27871 177966 32307614
Hospitalisation 24.48 10.83 95 27851 48876 32436704
Cardiac dysfunction 24.38 10.83 17 27929 1894 32483686
Low birth weight baby 22.66 10.83 29 27917 6965 32478615
Full blood count decreased 22.52 10.83 47 27899 16963 32468617
Upper gastrointestinal haemorrhage 21.82 10.83 57 27889 23792 32461788
Gingival hypertrophy 21.40 10.83 15 27931 1684 32483896
Normocytic anaemia 20.41 10.83 16 27930 2131 32483449
Transfusion 20.28 10.83 29 27917 7739 32477841
Dyspnoea 19.53 10.83 427 27519 361618 32123962
Off label use 19.52 10.83 169 27777 306151 32179429
Gastrointestinal angiodysplasia 19.36 10.83 10 27936 643 32484937
Pancreatic duct stenosis 19.26 10.83 7 27939 189 32485391
Pancreatic calcification 19.02 10.83 7 27939 196 32485384
Pancreatic mass 18.66 10.83 11 27935 917 32484663
Therapeutic product effect incomplete 17.18 10.83 7 27939 41334 32444246
Feeding intolerance 16.69 10.83 5 27941 72 32485508
Enterocolitis bacterial 16.46 10.83 7 27939 289 32485291
Microcytic anaemia 15.87 10.83 14 27932 2195 32483385
Weight gain poor 15.87 10.83 10 27936 940 32484640
Hepatic function abnormal 15.06 10.83 10 27936 44830 32440750
Flight of ideas 14.92 10.83 7 27939 365 32485215
Hyponatraemia 14.68 10.83 112 27834 74401 32411179
Asthma 14.57 10.83 10 27936 44055 32441525
Rectal haemorrhage 14.35 10.83 67 27879 37356 32448224
Pancreatic injury 14.27 10.83 5 27941 121 32485459
International normalised ratio increased 14.09 10.83 81 27865 48954 32436626
Suicide attempt 13.58 10.83 8 27938 38236 32447344
Cardiac ventricular disorder 13.40 10.83 6 27940 281 32485299
Mucosal inflammation 13.35 10.83 6 27940 33428 32452152
C-reactive protein increased 13.32 10.83 13 27933 48089 32437491
Asocial behaviour 13.08 10.83 4 27942 62 32485518
Ludwig angina 12.84 10.83 5 27941 164 32485416
Exposure during pregnancy 12.80 10.83 26 27920 9203 32476377
Treatment failure 12.80 10.83 9 27937 39154 32446426
Death 12.53 10.83 423 27523 382094 32103486
Foreign body aspiration 12.43 10.83 5 27941 179 32485401
Radiation proctitis 12.42 10.83 4 27942 74 32485506
Fluid overload 12.30 10.83 41 27905 19580 32466000
Suicidal ideation 12.12 10.83 9 27937 38074 32447506
Gastrointestinal tract mucosal pigmentation 12.01 10.83 6 27940 360 32485220
Failure to thrive 11.98 10.83 24 27922 8411 32477169
Right ventricular failure 11.93 10.83 24 27922 8439 32477141
Decubitus ulcer 11.89 10.83 24 27922 8457 32477123
Intentional overdose 11.80 10.83 11 27935 41590 32443990
Crystal urine 11.65 10.83 4 27942 91 32485489
Oxygen saturation decreased 11.64 10.83 76 27870 48023 32437557
Implant site inflammation 11.61 10.83 4 27942 92 32485488
Therapy interrupted 11.50 10.83 23 27923 8055 32477525
Iron deficiency 11.48 10.83 14 27932 3203 32482377
Tubulointerstitial nephritis 11.47 10.83 40 27906 19537 32466043
Acute respiratory failure 11.43 10.83 52 27894 28676 32456904
Bronchial disorder 11.22 10.83 9 27937 1239 32484341
Lip blister 11.20 10.83 7 27939 649 32484931
Hospice care 11.14 10.83 18 27928 5341 32480239
Cytomegalovirus infection 11.09 10.83 4 27942 25460 32460120
Drug resistance 11.09 10.83 3 27943 22962 32462618
Abnormal palmar/plantar creases 10.93 10.83 5 27941 246 32485334

Pharmacologic Action:

SourceCodeDescription
ATC B03AA07 BLOOD AND BLOOD FORMING ORGANS
ANTIANEMIC PREPARATIONS
IRON PREPARATIONS
Iron bivalent, oral preparations
ATC B03AD03 BLOOD AND BLOOD FORMING ORGANS
ANTIANEMIC PREPARATIONS
IRON PREPARATIONS
Iron in combination with folic acid
CHEBI has role CHEBI:63247 reductants

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Anemia of prematurity indication 47100003 DOID:11243
Megaloblastic anemia due to folate deficiency indication 85649008 DOID:14026
Vitamin deficiency indication 85670002
Iron deficiency anemia indication 87522002
Mineral deficiency indication 111379007
Mineral Deficiency Prevention indication
Vitamin Deficiency Prevention indication
Peptic ulcer contraindication 13200003 DOID:750
Operation on stomach contraindication 16453004
Primary hyperoxaluria contraindication 17901006 DOID:2977
Gastroenteritis contraindication 25374005 DOID:2326
Hemosiderosis contraindication 39011001 DOID:12119
Hemolytic anemia contraindication 61261009 DOID:583
Ulcerative colitis contraindication 64766004 DOID:8577
Anemia due to enzyme deficiency contraindication 111577008
Hb SS disease contraindication 127040003 DOID:10923
Esophageal dysmotility contraindication 266434009 DOID:9192
Diverticular disease contraindication 397881000
Hemochromatosis contraindication 399187006 DOID:2352
Repeated Blood Transfusions contraindication

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D04172 KEGG_DRUG
4017707 VUID
N0000146077 NUI
7782-63-0 SECONDARY_CAS_RN
4017662 VANDF
4017664 VANDF
4017707 VANDF
CHEBI:75832 CHEBI
CHEMBL1200830 ChEMBL_ID
C020748 MESH_SUPPLEMENTAL_RECORD_UI
39R4TAN1VT UNII
24393 PUBCHEM_CID
24947 RXNORM
4725 MMSL
4920 MMSL
6168 MMSL
63844 MMSL
d03824 MMSL
000840 NDDF
007813 NDDF
387402000 SNOMEDCT_US
71724000 SNOMEDCT_US
C0060282 UMLSCUI

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Quflora FE Pediatric Drops HUMAN PRESCRIPTION DRUG LABEL 14 15370-102 LIQUID 9.50 mg ORAL UNAPPROVED DRUG OTHER 11 sections
FERROUS SULFATE HUMAN OTC DRUG LABEL 1 50436-5890 TABLET 325 mg ORAL Unapproved drug other 10 sections
FERROUS SULFATE HUMAN OTC DRUG LABEL 1 53807-177 ELIXIR 220 mg ORAL UNAPPROVED DRUG OTHER 15 sections
FERROUS SULFATE HUMAN OTC DRUG LABEL 1 53808-0918 TABLET 325 mg ORAL UNAPPROVED DRUG OTHER 10 sections
Ferrous Sulfate HUMAN OTC DRUG LABEL 1 54738-963 TABLET 325 mg ORAL unapproved drug other 11 sections
Ferrous Sulfate HUMAN OTC DRUG LABEL 1 54738-963 TABLET 325 mg ORAL unapproved drug other 11 sections
FERROUS SULFATE HUMAN OTC DRUG LABEL 2 58607-113 TABLET 65 mg ORAL unapproved drug other 9 sections
Multi-Vitamin Drops with Fluoride and Iron HUMAN PRESCRIPTION DRUG LABEL 10 58657-327 LIQUID 10 mg ORAL unapproved drug other 10 sections
Ferrous Sulfate HUMAN OTC DRUG LABEL 1 67296-1555 TABLET, FILM COATED 325 mg ORAL unapproved drug other 10 sections
Ferrous Sulfate HUMAN PRESCRIPTION DRUG LABEL 1 69517-133 TABLET 65 mg ORAL unapproved drug other 6 sections
Ferrous Sulfate Human OTC Drug Label 1 76413-308 TABLET, FILM COATED 325 mg ORAL UNAPPROVED DRUG OTHER 10 sections
Ferrous Sulfate Human OTC Drug Label 1 76413-356 TABLET, FILM COATED 325 mg ORAL UNAPPROVED DRUG OTHER 11 sections